Emerging Treatments

Ampicillin Plus Ceftriaxone: An Effective Alternative for <i>E faecalis</i> Infective Endocarditis

Ampicillin Plus Ceftriaxone: An Effective Alternative for E faecalis Infective Endocarditis

By

Ampicillin plus ceftriaxone was an effective treatment for penicillin-susceptible Enterococcus faecalis infective endocarditis compared with ampicillin plus gentamicin.

Mulpleta Approved for Thrombocytopenia in Patients With Chronic Liver Disease

Mulpleta Approved for Thrombocytopenia in Patients With Chronic Liver Disease

By

The FDA has approved Mulpleta for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

Hep B Core Antibody-Positive Organs May Provide Solutions to the Organ Donor Crisis

Hep B Core Antibody-Positive Organs May Provide Solutions to the Organ Donor Crisis

Hepatitis B core Antibody (anti-HB c+) organs may be a safe and ethical transplant option in an era where increased medical knowledge has enabled greater treatment for hepatitis.

Continuous Antibiotic Infusion via Elastomeric Pumps Safe and Effective in Outpatients

Continuous Antibiotic Infusion via Elastomeric Pumps Safe and Effective in Outpatients

By

Treating outpatients with continuous infusions of flucloxacillin, cefepime, vancomycin, and piperacillin/tazobactam using elastomeric pumps was effective and safe.

Could Zika Virus Be a Potential Treatment for Neuroblastoma?

Could Zika Virus Be a Potential Treatment for Neuroblastoma?

By

Even with intensive therapy, survival among neuroblastoma patients is poor, indicating a need for alternative treatments.

Zemdri Now Available for the Treatment of Complicated UTI, Pyelonephritis

Zemdri Now Available for the Treatment of Complicated UTI, Pyelonephritis

By

Zemdri carries a Boxed Warning describing reports of nephrotoxicity, ototoxicity, and neuromuscular blockade, as well as fetal harm if administered during pregnancy.

TPOXX Approved for the Treatment of Human Smallpox Disease

TPOXX Approved for the Treatment of Human Smallpox Disease

By

The approval was supported by findings from 12 clinical trials of TPOXX with more than 700 healthy volunteers that showed no drug-related serious adverse events.

Using Genome Mapping to Fight Antibiotic Resistance Bacteria

Using Genome Mapping to Fight Antibiotic Resistance Bacteria

Whole genome sequencing is being used by the US Food and Drug Administration to combat the global spread of antibiotic resistance bacteria.

FDA Green Lights Combination Medication for Treating HIV-1

FDA Green Lights Combination Medication for Treating HIV-1

Gilead Sciences announced that the FDA has approved emtricitabine/tenofovir alafenamide [F/TAF] (Descovy) tablets for the treatment of HIV-1 infection.

FDA Green Lights Odefsey for Treating HIV-1

FDA Green Lights Odefsey for Treating HIV-1

By

Combining emtricitabine and tenofovir alafenamide (Gilead Sciences) and rilpivirine (Janssen Sciences), Odefsey is Gilead's second tenofovir alafenamide-based regimen to receive FDA approval.

Drop-to-Drop Variation Noted With Fingerprick Blood

Drop-to-Drop Variation Noted With Fingerprick Blood

Authors say variation in blood analytes holds implications for point-of-care testing.

Antiretroviral Therapy For All (Almost)

Antiretroviral Therapy For All (Almost)

An international randomized trial resolves the debate about the timing for the initiation of antiretroviral therapy for patients.

Preventive HIV Treatment Proving Effective at Health Clinics

Preventive HIV Treatment Proving Effective at Health Clinics

But uptake of PrEP lower among blacks.

Years Leading Up To Violent Conflict May Be Time of High HIV Transmission

Years Leading Up To Violent Conflict May Be Time of High HIV Transmission

The study tracked HIV incidence statistics in 36 sub-Saharan countries from 1990 through 2012 and correlated them with periods of conflict and peace in each country.

Sign Up for Free e-newsletters